Papers/PMID:41037125
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.
Inflammopharmacology2025The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
resveratrol — decreases visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol treatment significantly reduced pain intensity and WOMAC scores, while increasing OKS scores, ROM, gait velocity, HGS, and overall SPPB performance (p < 0.05).”
Quoted verbatim from Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 500 mg/day
- Population
- Patients with knee osteoarthritis, aged 63-73 years, in a 12-week double-blind placebo-controlled trial (n=122 analyzed after dropouts: placebo n=65, resveratrol n=57)
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.2025PMID:41037125Permalink